What is the ticker symbol for Kiora Pharmaceuticals?

Kiora Pharmaceuticals trades under the ticker KPRX on NASDAQ.

What sector does Kiora Pharmaceuticals operate in?

Kiora Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze KPRX in a portfolio?

PortView shows KPRX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Kiora Pharmaceuticals (KPRX) Stock Analysis

NASDAQHealthcareBiotechnology

$2.61+4.08%

1-year price historyRange $1.80 – $2.86

52-week range$2.61

$1.77$2.95

What Kiora Pharmaceuticals does

Kiora Pharmaceuticals, Inc., a specialty pharmaceutical firm operating at the clinical stage, is dedicated to the creation and commercialization of treatments for various ophthalmic conditions across the United States. Its flagship therapeutic candidate, KIO-301, is a groundbreaking small molecule undergoing Phase 1 clinical trials. This innovative "photoswitch" aims to revitalize vision in individuals suffering from both inherited and age-related forms of retinal degeneration. The company's pipeline also includes KIO-101, an eye drop currently in Phase 2 trials for addressing the ocular manifestations of rheumatoid arthritis, as well as non-infectious posterior uveitis. Furthermore, Kiora is advancing KIO-201, another eye drop, which is in Phase 3 clinical trials, designed to facilitate corneal wound healing following PRK surgery. Established in 1998, the company adopted its current name in November 2021, having previously operated as Eyegate Pharmaceuticals, Inc. Kiora Pharmaceuticals maintains its corporate headquarters in Salt Lake City, Utah.

Key metrics

Market cap

$11.58M

P/E (TTM)

-1.04

EPS (TTM)

$-2.51

Beta

-0.39

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$2.57

200-day avg

$2.32

52-week high

$2.95

52-week low

$1.77

CEO

Brian Strem

ETFs linked to KPRX

Broad-market and Healthcare sector ETFs an investor holding Kiora Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how KPRX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze KPRX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Kiora Pharmaceuticals?: Kiora Pharmaceuticals trades under the ticker KPRX on NASDAQ.
Which exchange is KPRX listed on?: KPRX is listed on NASDAQ.
What sector does Kiora Pharmaceuticals operate in?: Kiora Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze KPRX in a portfolio?: PortView shows KPRX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.